A study testing whether a GLP-1 medicine, liraglutide, can help people with maturity-onset diabetes of the young (MODY) lower blood sugar.

Recruiting now. Registry record last updated December 17, 2025.

Who can join: Ages 10+, have maturity-onset diabetes of the young (MODY), BMI 18.5+.
What you take: Liraglutide, given as part of the study. Check ClinicalTrials.gov for this trial's study groups, including any placebo or comparison medicine.
How long it lasts: The full study runs about 2 years.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Phase 2Sponsor MansaDrug liraglutideClass GLP-1 RASites 1 USEnrollment target 50

What this study is for

Primary condition: Maturity Onset Diabetes of the Young.

Full scientific study title: Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY).

Who can join

Age10 and upSexAnyBMI18.5 or higher

Ages 10+, have maturity-onset diabetes of the young (MODY), BMI 18.5+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Diagnosis of MODY via genetic testing
HgbA1c \>6.5%

Key exclusion criteria

History of anaphylaxis to GLP-1 receptor agonists
Already taking GLP-1 receptor agonists
on medications within the stimulant class
have had bariatric surgery
personal or family history of cancer, especially medullary thyroid cancer

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Ohio1 site

Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Lily Deng513-636-0002lily.deng@cchmc.org

Follow this trial

We email you if NCT07029009 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: May 8, 2025. Expected completion: January 2027. Last updated on ClinicalTrials.gov: December 17, 2025.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.